Share this page!

Suzanne Nielsen PhD MPS Profile picture
Twitter logo
Jun 12 • 4 tweets • 2 min read
Really important study being presented by Staci Gruber at #CPDD22 which longitudinally assesses a whole range of functioning in cannabis naive ppl before and following use of medical cannabis (now 3 years of follow up funded) 1/
2/ most interested in use for pain, detailed info collected on cannabinoid use..including developing the cannacount metric to measure cannabinoid use
Most are using CBD dominant products, which include a range of other minor cannabinoids including CBG and CBC
Higher exposure to CBD appears to be associated with better mood related outcomes, and lower pain distress in the pain subset

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Suzanne Nielsen PhD MPS

Suzanne Nielsen PhD MPS Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @DrSuziNielsen

Suzanne Nielsen PhD MPS Profile picture
Jun 13
At the #CPDD22 mini-symposium on #gabapentin talks about considerable research highlighting potential for SUD treatment but also high rates of identification in overdose. Prescribing continues to increase yet diversion appears to trend down after regulatory changes 1/
2/ anecdotal reports of #gabapentin enhancing opioid effects and reducing withdrawal. Motivation for use is a mix of non-medical use with other substances and therapeutic motivations e.g. to self manage pain/withdrawal
3/ increases in gapabentin increase in a linear manner compared with low/stable pregabalin prescribing (interesting this is reversed in Australia) - it is commonly being prescribed off label for substance use treatment
Read 10 tweets
Suzanne Nielsen PhD MPS Profile picture
Jun 12
David Ledgerwood talks about a pharmacist delivered contingency management in people with HIV who smoke - and of course I am super excited to see #pharmacists deliver these interventions #cpdd22 1/
2/ can pharmacists be trained to deliver contingency management for smoking cessation?
3/ yes! Of course they can. Pharmacists do really well in terms of delivering contingency management, especially discussing smoking and praising efforts and being generally skilful in smoking cessation
Read 4 tweets
Suzanne Nielsen PhD MPS Profile picture
Nov 16, 2021
"Won't giving people #naloxone increase their drug use?" I get this question almost every time I deliver training to healthcare professionals. Superstar student @WaiChungTse1 led this systematic review to examine this common concern 1/ (FREE to download)
authors.elsevier.com/c/1e5JG_LkIBSl…
2/ So what did we do? We looked for studies where substance use and overdose was measured before and after naloxone provision. We found no evidence that take-home naloxone leads to increased substance use or overdose. 1 study found reduced ED attendances following naloxone supply
3/ So if you are providing naloxone, or thinking about it, this might be reassuring. If you train pharmacists, doctors, first responders etc and they have concern.. please feel free to share this work with them! @PSA_National @RACGP @ijdrugpolicy
authors.elsevier.com/c/1e5JG_LkIBSl…
Read 4 tweets
Suzanne Nielsen PhD MPS Profile picture
Nov 10, 2021
Last session for me today at @APSAD40 on prescription opioids, treatment, and prescription drug monitoring programs. First up - a mini-symposium with @PPrathivadi , @LouisaPicco and @Sarah_Haines_ .. lets see if I can pull out a few key findings 1/
2/ First up @PPrathivadi talking about GPs use of PDMP, benefits for informing prescribing but challenges with reluctance to use technology - also check out this super commentary with @Sarah_Haines_ in the @AusJPrimHealth on evaluation considerations
publish.csiro.au/py/PY20296
3/ Next is @LouisaPicco talking about implementation of prescription monitoring with #pharmacists. Alerts seem to really drive responses (over other clinical risk factors).. are automatic alerts replacing clinical judgement? Conclusion: PDMP should not replace clinical decisions
Read 8 tweets
Suzanne Nielsen PhD MPS Profile picture
Nov 10, 2021
Last afternoon of #APSAD40! It is a joy to chair this session on #overdose - lots of key learnings and great work in the prevention space. Here are a couple of highlights from the session 1/
2/ Louisa Durrant (NUM at Melaleuca, @qldhealthnews) spoke about lessons learned supplying take-home naloxone in the opioid treatment program in QLD. Despite many having experienced an overdose, few had access to naloxone before the pilot, and consumers valued being offered THN.
3/ Dr Eleanor Black presented on the ONE study, a pilot study looking at ED delivery of #naloxone - a key opportunity to offer naloxone to people at risk of overdose. Most (not all) staff through they should offer #naloxone, with common misconception of naloxone increased OD risk
Read 11 tweets
Suzanne Nielsen PhD MPS Profile picture
Nov 9, 2021
What's new in take-home #naloxone in Australia? 1/ Ange Matheson from @NSWHealth explains the NSW model which allows a whole range of workers and non-medical services across the NSW (e.g. those working NGOs without pharmacists or doctors on staff) to supply naloxone #APSAD40
2/ Tegan Nuckey from Queensland (QuIHN) talks about their #naloxone program, adapted from the WA model.. now funded until 2023 (but no recurrent funding). Hopefully a national program will be funded by then! No cost, script, no ID - addressing key barriers.
3/ Robin Greaves (Tasmania) presented on the Tasmanian gov program where poisons regulations were changed to allow supply by NPS workers as part of their pilot. With limited funding, the pilot focused on people who use heroin, now ongoing funding provides FREE naloxone from NSPs
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(